Healthcare | August 28, 2023
IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Aurobindo will respond to the US FDA within the stipulated timelines
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Approval to dramatically change CAR-T therapies landscape
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
The drug exhibited greater treatment persistence and control of moderate-to-severe PsO symptoms compared to secukinumab and ixekizumab
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Subscribe To Our Newsletter & Stay Updated
